| NCT04461002 |
Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas. |
https://ClinicalTrials.gov/show/NCT04461002 |
Enrolling by invitation |
GCS Ramsay Santé pour l’Enseignement et la Recherche |
2020-12-31 |
| NCT04097535 |
Measuring Fatty Acid Oxidation in Gliomas Using 18F-FPIA PET/MRI |
https://ClinicalTrials.gov/show/NCT04097535 |
Recruiting |
Imperial College London |
2020-08-01 |
| NCT03180697 |
The Efficacy of APT Magnetic Resonance Imaging in Predicting the Efficacy of Bevacizumab in Recurrent Malignant Gliomas |
https://ClinicalTrials.gov/show/NCT03180697 |
Recruiting |
Zhujiang Hospital |
2021-09-30 |
| NCT03101813 |
International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository |
https://ClinicalTrials.gov/show/NCT03101813 |
Recruiting |
Children’s Hospital Medical Center, Cincinnati |
2037-06-30 |
| NCT02747407 |
Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors |
https://ClinicalTrials.gov/show/NCT02747407 |
Active, not recruiting |
Wake Forest University Health Sciences |
2019-04-17 |
| NCT02731521 |
Clinical Development of MR Spectroscopy and Imaging in Brain Cancers |
https://ClinicalTrials.gov/show/NCT02731521 |
Recruiting |
University of Texas Southwestern Medical Center |
2020-12-31 |
| NCT02728024 |
Assessing Psychosocial and Supportive Care Needs in Patients With Gliomas |
https://ClinicalTrials.gov/show/NCT02728024 |
Completed |
Johannes Gutenberg University Mainz |
2015-03-31 |
| NCT02652897 |
Hemostasis Alterations in Neurosurgical Patients |
https://ClinicalTrials.gov/show/NCT02652897 |
Recruiting |
Hospitales Universitarios Virgen del RocÃo |
2019-02-28 |
| NCT02607397 |
ROCOCO - Low Grade Glioma - Planning Study |
https://ClinicalTrials.gov/show/NCT02607397 |
Completed |
Maastricht Radiation Oncology |
2017-03-31 |
| NCT02023346 |
Prognostic Awareness and Patient-Physician Communication in Malignant Glioma |
https://ClinicalTrials.gov/show/NCT02023346 |
Completed |
Memorial Sloan Kettering Cancer Center |
2018-10-30 |
| NCT02558335 |
CTCs for High Grade Glioma |
https://ClinicalTrials.gov/show/NCT02558335 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2017-04-30 |
| NCT02391246 |
Radionecrosis and FDG PET |
https://ClinicalTrials.gov/show/NCT02391246 |
Recruiting |
Ottawa Hospital Research Institute |
2020-03-31 |
| NCT02388659 |
Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas |
https://ClinicalTrials.gov/show/NCT02388659 |
Recruiting |
University of Texas Southwestern Medical Center |
2020-12-31 |
| NCT02300532 |
Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study) |
https://ClinicalTrials.gov/show/NCT02300532 |
Completed |
Eisai Inc. |
2014-07-10 |
| NCT02300506 |
Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma |
https://ClinicalTrials.gov/show/NCT02300506 |
Completed |
Eisai Inc. |
2016-07-10 |
| NCT02186262 |
Rotating Frame Relaxation and Diffusion Weighted Imaging of Human Gliomas |
https://ClinicalTrials.gov/show/NCT02186262 |
Completed |
Turku University Hospital |
2017-12-31 |
| NCT01811524 |
The Etiology and Progression of Brain Tumors |
https://ClinicalTrials.gov/show/NCT01811524 |
Completed |
Tampere University Hospital |
2009-12-31 |
| NCT01417507 |
Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery |
https://ClinicalTrials.gov/show/NCT01417507 |
Completed |
Radiation Therapy Oncology Group |
2014-12-31 |
| NCT04423094 |
Foci of Tumor Heterogeneity in Diffuse Low-Grade Gliomas |
https://ClinicalTrials.gov/show/NCT04423094 |
Completed |
University Hospital, Montpellier |
2019-03-01 |
| NCT04346472 |
Longitudinal MRI Assessment in Patients With Diffuse Low-grade Gliomas |
https://ClinicalTrials.gov/show/NCT04346472 |
Completed |
University Hospital, Montpellier |
2019-12-30 |
| NCT04216537 |
Survival Significance of Molecular Pathology and Genetic Variation in Brain Gliomas |
https://ClinicalTrials.gov/show/NCT04216537 |
Recruiting |
The First Affiliated Hospital of Zhengzhou University |
2025-01-01 |
| NCT04215211 |
MR Based Survival Prediction of Glioma Patients Using Artificial Intelligence |
https://ClinicalTrials.gov/show/NCT04215211 |
Recruiting |
The First Affiliated Hospital of Zhengzhou University |
2027-01-01 |
| NCT04194593 |
Biomarker-based Algorithm for Diagnosis of Glioma |
https://ClinicalTrials.gov/show/NCT04194593 |
Active, not recruiting |
Hospices Civils de Lyon |
2020-03-01 |
| NCT04122521 |
Radiogenomic and Prognosis Analysis in Glioma |
https://ClinicalTrials.gov/show/NCT04122521 |
Recruiting |
Asan Medical Center |
2021-02-28 |
| NCT04055688 |
Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas |
https://ClinicalTrials.gov/show/NCT04055688 |
Active, not recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2019-12-17 |
| NCT04013828 |
Treatment Decision-making in Patients With Recurrent High-grade Glioma |
https://ClinicalTrials.gov/show/NCT04013828 |
Recruiting |
Odense University Hospital |
2020-07-31 |
| NCT04001257 |
18F-Fluoro-Ethyl-Tyrosine (FET) Positron Emission Tomography (PET) and Grading Glioma |
https://ClinicalTrials.gov/show/NCT04001257 |
Completed |
University Hospital, Brest |
2019-09-17 |
| NCT04000048 |
Molecular Heterogeneity in Multilobar Low-grade Gliomas |
https://ClinicalTrials.gov/show/NCT04000048 |
Recruiting |
University Hospital, Montpellier |
2020-06-30 |
| NCT03973892 |
Remote Brain Microhaemorrhages May Predict Haematoma in Glioma Patients Treated With Radiation Therapy |
https://ClinicalTrials.gov/show/NCT03973892 |
Completed |
Fondation Ophtalmologique Adolphe de Rothschild |
2016-01-31 |
| NCT03949192 |
Efficacy of Kangliuwan for Recurrent Grade IV Glioma |
https://ClinicalTrials.gov/show/NCT03949192 |
Recruiting |
Xuanwu Hospital, Beijing |
2021-06-30 |
| NCT03091270 |
ZOOMit-fMRI Identifies Motor Functional Cortex |
https://ClinicalTrials.gov/show/NCT03091270 |
Recruiting |
Beijing Neurosurgical Institute |
2022-01-01 |
| NCT03877861 |
Validation of Readibandâ„¢ Actigraph and Associated Sleep/Wake Classification Algorithms |
https://ClinicalTrials.gov/show/NCT03877861 |
Recruiting |
Allina Health System |
2020-12-31 |
| NCT03865355 |
Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients |
https://ClinicalTrials.gov/show/NCT03865355 |
Recruiting |
Novosibirsk State University |
2024-04-11 |
| NCT02965144 |
Long Term Survivors of High-grade Glioma and Their Caregivers |
https://ClinicalTrials.gov/show/NCT02965144 |
Completed |
Rigshospitalet, Denmark |
2017-06-30 |
| NCT03706625 |
Integrated Discovery of New Immuno-Molecular Actionable Biomarkers for Tumors With Immune-suppressed Environment |
https://ClinicalTrials.gov/show/NCT03706625 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2021-10-31 |
| NCT03698201 |
Blood Biomarker Signature in Glioma |
https://ClinicalTrials.gov/show/NCT03698201 |
Recruiting |
Cancer Trials Ireland |
2022-07-31 |
| NCT03677999 |
Spectroscopic Magnetic Resonance Imaging of Glioma |
https://ClinicalTrials.gov/show/NCT03677999 |
Recruiting |
University of Minnesota |
2024-09-14 |
| NCT03593993 |
A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas |
https://ClinicalTrials.gov/show/NCT03593993 |
Recruiting |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2021-05-19 |
| NCT03496181 |
Evaluation of Functional Magnetic Resonance Imaging (fMRI) in Patients Who Speak Two Languages Fluently |
https://ClinicalTrials.gov/show/NCT03496181 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-09-30 |
| NCT01225003 |
Advanced MR Techniques in Detection of Tumor Infiltration and Grading in Gliomas |
https://ClinicalTrials.gov/show/NCT01225003 |
Completed |
Universitaire Ziekenhuizen Leuven |
NA |
| NCT01212731 |
Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study |
https://ClinicalTrials.gov/show/NCT01212731 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2015-08-31 |
| NCT01191346 |
Radiation Planning Study for High Grade Brain Tumors |
https://ClinicalTrials.gov/show/NCT01191346 |
Completed |
University of Cincinnati |
2013-03-31 |
| NCT01138813 |
Development of Magnetic Resonance Spectroscopy (MRS) Biomarkers of Tumor Metabolism (MK-0000-145) |
https://ClinicalTrials.gov/show/NCT01138813 |
Completed |
Merck Sharp & Dohme Corp. |
2010-02-28 |
| NCT01106794 |
Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma |
https://ClinicalTrials.gov/show/NCT01106794 |
Recruiting |
Children’s National Research Institute |
2025-04-30 |
| NCT01004523 |
Study of Tissue and Blood Samples From Patients With Low-Grade Glioma |
https://ClinicalTrials.gov/show/NCT01004523 |
Completed |
Alliance for Clinical Trials in Oncology |
2013-03-31 |
| NCT00967200 |
Study of Tissue Samples From Patients With Glioma or Other Brain Tumors |
https://ClinicalTrials.gov/show/NCT00967200 |
Completed |
University Hospital, Montpellier |
2009-07-31 |
| NCT00939315 |
Multimodal Diagnostic Assessment of Cerebral Gliomas With FET & FCH PET/CT, and Magnetic Resonance Imaging/Spectroscopy |
https://ClinicalTrials.gov/show/NCT00939315 |
Completed |
University of Lausanne Hospitals |
2016-01-31 |
| NCT00898755 |
Collecting and Storing Tissue From Young Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00898755 |
Completed |
Children’s Oncology Group |
2008-07-17 |
| NCT00899834 |
DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma |
https://ClinicalTrials.gov/show/NCT00899834 |
Completed |
St. Jude Children’s Research Hospital |
2015-08-31 |
| NCT00942760 |
Protocol to Distinguish Tumor Recurrence From Treatment-Related Necrosis in Patients With High Grade Gliomas |
https://ClinicalTrials.gov/show/NCT00942760 |
Completed |
Dartmouth-Hitchcock Medical Center |
2011-03-31 |
| NCT01009307 |
Study of Blood and Cheek Cell Samples From Patients With Glioma |
https://ClinicalTrials.gov/show/NCT01009307 |
Completed |
University of California, San Francisco |
2006-07-31 |
| NCT02632370 |
5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor |
https://ClinicalTrials.gov/show/NCT02632370 |
Completed |
Icahn School of Medicine at Mount Sinai |
2018-12-31 |
| NCT00339352 |
A Family Study of Adults With Glioma |
https://ClinicalTrials.gov/show/NCT00339352 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02473484 |
Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas |
https://ClinicalTrials.gov/show/NCT02473484 |
Completed |
University Hospital, Lille |
2017-10-31 |
| NCT00705198 |
Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062) |
https://ClinicalTrials.gov/show/NCT00705198 |
Completed |
Merck Sharp & Dohme Corp. |
2016-07-31 |
| NCT00561873 |
Nimotuzumab in Children With HGG |
https://ClinicalTrials.gov/show/NCT00561873 |
Completed |
Oncoscience AG |
NA |
| NCT00561691 |
Nimotuzumab in Children With Intrinsic Pontine Glioma |
https://ClinicalTrials.gov/show/NCT00561691 |
Completed |
Oncoscience AG |
NA |
| NCT00418899 |
Gliogene: Brain Tumor Linkage Study |
https://ClinicalTrials.gov/show/NCT00418899 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2022-09-01 |
| NCT00352820 |
Experience of Brain Tumor Caregivers |
https://ClinicalTrials.gov/show/NCT00352820 |
Completed |
M.D. Anderson Cancer Center |
2006-12-31 |
| NCT00283569 |
Genetic Epidemiology of Adult Onset Glioma |
https://ClinicalTrials.gov/show/NCT00283569 |
Completed |
Kentuckiana Cancer Institute |
2010-01-31 |
| NCT00214175 |
Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy |
https://ClinicalTrials.gov/show/NCT00214175 |
Completed |
University of Wisconsin, Madison |
2011-01-31 |
| NCT00201903 |
The Roles of Tissue Factor in Malignant Gliomas |
https://ClinicalTrials.gov/show/NCT00201903 |
Completed |
Ontario Clinical Oncology Group (OCOG) |
NA |
| NCT00137488 |
Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG) |
https://ClinicalTrials.gov/show/NCT00137488 |
Completed |
AHS Cancer Control Alberta |
2007-12-31 |
| NCT00125710 |
Comparative 2-D Tumor Analysis in Familial Gliomas |
https://ClinicalTrials.gov/show/NCT00125710 |
Completed |
AHS Cancer Control Alberta |
2012-08-31 |
| NCT00125697 |
Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing Radiotherapy |
https://ClinicalTrials.gov/show/NCT00125697 |
Completed |
AHS Cancer Control Alberta |
2015-06-30 |
| NCT00059020 |
The Role of Gene Changes in Brain Tumor Formation and Growth |
https://ClinicalTrials.gov/show/NCT00059020 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001171 |
Evaluation of Factors in Human Brain Tumors |
https://ClinicalTrials.gov/show/NCT00001171 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00285324 |
Diffusion Tensor MRI to Distinguish Brain Tumor Recurrence From Radiation Necrosis |
https://ClinicalTrials.gov/show/NCT00285324 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00009035 |
Natural History of Patients With Brain and Spinal Cord Tumors |
https://ClinicalTrials.gov/show/NCT00009035 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001148 |
Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor |
https://ClinicalTrials.gov/show/NCT00001148 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |